Daniel A.C. Fisher

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
  2025 L1 73/100

1 assessed by us (0 reproduced) · 73 not yet assessed — every PubMed paper on record, linked below.

• Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms ↗

  Blood · 2026 · PMID 42345360
  not yet assessed
• RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia

  Nature Communications · 2025 · PMID 39820365
  L1 73/100
• A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies ↗

  Cell Communication and Signaling · 2025 · PMID 41402890
  not yet assessed
• In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms ↗

  Blood · 2024 · PMID 38457657
  not yet assessed
• Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms ↗

  Experimental Hematology · 2024 · PMID 38340948
  not yet assessed
• Monocyte-Driven Aberrant Inflammation in Myeloproliferative Neoplasms Is Regulated By Galectin-1 ↗

  Blood · 2024
  not yet assessed
• JAK2-V617F Expression Results in a Cell-Intrinsic Expansion of Megakaryocyte Progenitors with Evidence of Myc Pathway Activation in Both Mature and Precursor Megakaryocytes By Single Cell RNA Sequencing ↗

  Blood · 2024
  not yet assessed
• Construction of a Myeloid Gene Signature Revealing Novel Therapeutic Targets for Myeloid Malignancies ↗

  Blood · 2024
  not yet assessed
• IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry ↗

  Nature Communications · 2023 · PMID 36959190
  not yet assessed
• Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms ↗

  Journal of Clinical Investigation · 2023 · PMID 38060311
  not yet assessed
• Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms ↗

  American Journal of Hematology · 2023 · PMID 37203407
  not yet assessed
• Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice ↗

  Experimental Hematology · 2023 · PMID 37611729
  not yet assessed
• RSK1 Is an Exploitable Dependency in Myeloid Malignancies ↗

  Blood · 2023
  not yet assessed
• Data from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Supplementary Figures from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Supplementary Figures from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Data from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Supplementary Table 1 from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Supplementary Table 1 from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Supplementary Table 2 from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Supplementary Table 2 from A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  2023
  not yet assessed
• Leukemic Driver Clones Can Arise Independently and Outcompete MPN Cells in Post-MPN Secondary AML ↗

  Blood · 2023
  not yet assessed
• In Vivo Ablation of NFκB Cascade Effectors Alleviates Disease Burden in Myeloproliferative Neoplasms ↗

  Blood · 2023
  not yet assessed
• Galectin-1 Fuels Monocyte-Driven Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms ↗

  Blood · 2023
  not yet assessed
• DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression ↗

  Nature Cancer · 2022 · PMID 36581736
  not yet assessed
• Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib ↗

  British Journal of Haematology · 2022 · PMID 35128632
  not yet assessed
• Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes ↗

  Experimental Hematology · 2022 · PMID 35367529
  not yet assessed
• IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Multiomic Profiling Reveals Metabolic Alterations Mediating Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Human bone marrow IMC dataset and simulation dataset ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2022
  not yet assessed
• Results of IMC-Denoise: a content aware pipeline to enhance Imaging Mass Cytometry ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2022
  not yet assessed
• Transcriptional and Metabolic Profiling Reveals Alpha-Ketoglutarate As a Novel Mediator of Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms ↗

  Blood · 2022
  not yet assessed
• Results of IMC-Denoise: a content aware pipeline to enhance Imaging Mass Cytometry ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2022
  not yet assessed
• Human bone marrow IMC dataset and simulation dataset ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2022
  not yet assessed
• Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition ↗

  Blood Advances · 2021 · PMID 34644371
  not yet assessed
• DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• DUSP6 Mediates Resistance to JAK2 Inhibition and Drives Myeloproliferative Neoplasm Disease Progression ↗

  Blood · 2021
  not yet assessed
• The Transmembrane Protein Semaphorin 6A Repels Embryonic Sympathetic Axons ↗

  Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2021
  not yet assessed
• Unraveling the Architecture of Classic Hodgkin Lymphoma One Cell at a Time ↗

  Cancer Discovery · 2020 · PMID 32127404
  not yet assessed
• Imaging Mass Cytometry Reveals the Spatial Architecture of Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemias ↗

  Blood · 2020
  not yet assessed
• A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• A Novel Humanized Animal Model Reveals Clonal Architecture and Therapeutic Vulnerabilities in Myelofibrosis ↗

  Blood · 2020
  not yet assessed
• Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling ↗

  Leukemia · 2019 · PMID 30718771
  not yet assessed
• Altered Dynamics of Monocyte Subpopulations and Pro-Inflammatory Signaling Pathways in Polycythemia Vera Revealed By Mass Cytometry ↗

  Blood · 2019
  not yet assessed
• JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells ↗

  Cancer Cell · 2018 · PMID 30423295
  not yet assessed
• Identification of functionally primitive and immunophenotypically distinct subpopulations in secondary acute myeloid leukemia by mass cytometry ↗

  Cytometry Part B Clinical Cytometry · 2018 · PMID 30426661
  not yet assessed
• An all-diamond X-ray position and flux monitor using nitrogen-incorporated ultra-nanocrystalline diamond contacts ↗

  Journal of Synchrotron Radiation · 2018 · PMID 29979167
  not yet assessed
• Hepcidin Is Elevated in Primary and Secondary Myelofibrosis and Correlates with IL-6 and IL-2Rα but Is High in Patients Treated with Ruxolitinib ↗

  Blood · 2018
  not yet assessed
• Aberrant Cytokine Production in Myelofibrosis Is Not Rectified By Ruxolitinib and Is Differentially Sensitive to Inhibition of JAK/STAT, MAP Kinase, and NFκB Signaling ↗

  Blood · 2018
  not yet assessed
• Analysis of Signaling Networks at the Single-Cell Level Using Mass Cytometry ↗

  Methods in molecular biology · 2017 · PMID 28730492
  not yet assessed
• playing god eradicating malaria and mosquitoes in the developing world with gene drives and crispr cas9

  2017
  not yet assessed
• Identification of Functionally Primitive and Immunophenotypically Distinct Subpopulations in Secondary Acute Myeloid Leukemia By Mass Cytometry ↗

  Blood · 2016
  not yet assessed
• Mass Cytometry Analysis of Dysregulated Cytokine Production and Intracellular Signaling in Myelofibrosis ↗

  Blood · 2016
  not yet assessed
• Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia ↗

  Blood · 2016
  not yet assessed
• Dry graphene transfer print to polystyrene and ultra-high molecular weight polyethylene − Detailed chemical, structural, morphological and electrical characterization ↗

  Carbon · 2015
  not yet assessed
• Applications of Single-Cell Mass Cytometry (CyTOF) in Hematologic Malignancies ↗

  The Hematologist · 2015
  not yet assessed
• NF Kappa B Signaling Hyperactivation in Myelofibrosis and Secondary Acute Myeloid Leukemia ↗

  Blood · 2015
  not yet assessed
• Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease ↗

  Neurobiology of Disease · 2014 · PMID 24969022
  not yet assessed
• Single Cell Mass Cytometry Reveals Hyperactivated Signaling Networks in Myeloproliferative Neoplasms ↗

  Blood · 2014
  not yet assessed
• Whole-rat conditional gene knockout via genome editing ↗

  Nature Methods · 2013 · PMID 23749298
  not yet assessed
• SEC14 and Spectrin Domains 1 (Sestd1), Dishevelled 2 (Dvl2) and Dapper Antagonist of Catenin-1 (Dact1) co-regulate the Wnt/Planar Cell Polarity (PCP) pathway during mammalian development ↗

  Communicative & Integrative Biology · 2013 · PMID 24505507
  not yet assessed
• Erratum: Corrigendum: Whole-rat conditional gene knockout via genome editing ↗

  Nature Methods · 2013
  not yet assessed
• Mass Cytometry Analysis Of Myelofibrosis and Secondary Acute Myeloid Leukemia Reveals Constitutive and Cytokine Induced Signaling Abnormalities With Differential Sensitivities To Ruxolitinib ↗

  Blood · 2013
  not yet assessed
• Concomitant JAK2 V617F-Positive Polycythemia Vera and BCR-ABL-Positive Chronic Myelogenous Leukemia Treated with Ruxolitinib and Dasatinib. ↗

  Blood · 2012
  not yet assessed
• Clonal Evolution Revealed by Whole Genome Sequencing in a Case of Primary Myelofibrosis Transformed to Secondary Acute Myeloid Leukemia ↗

  Blood · 2012
  not yet assessed
• Single Cell Mass Cytometry of Dysregulated Signaling Networks in Myeloproliferative Neoplasms and Secondary Acute Myeloid Leukemia ↗

  Blood · 2012
  not yet assessed
• Targeted integration in rat and mouse embryos with zinc-finger nucleases ↗

  Nature Biotechnology · 2010 · PMID 21151125
  not yet assessed
• In Situ X-ray Absorption Spectroscopy of the Oxygen in a Li-Ion Battery ↗

  ECS Meeting Abstracts · 2010
  not yet assessed
• Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak ↗

  Nature Genetics · 2009 · PMID 19701191
  not yet assessed
• Three Dact gene family members are expressed during embryonic development and in the adult brains of mice ↗

  Developmental Dynamics · 2006 · PMID 16881060
  not yet assessed
• Dact1 presomitic mesoderm expression oscillates in phase with Axin2 in the somitogenesis clock of mice ↗

  Developmental Dynamics · 2006 · PMID 17013874
  not yet assessed
• Dendritic Spines Lost during Glutamate Receptor Activation Reemerge at Original Sites of Synaptic Contact ↗

  Journal of Neuroscience · 2001 · PMID 11264313
  not yet assessed
• The Transmembrane Protein Semaphorin 6A Repels Embryonic Sympathetic Axons ↗

  Journal of Neuroscience · 2000 · PMID 10729344
  not yet assessed
• Analysis of the palmitoylation and membrane targeting domain of neuromodulin (GAP-43) by site-specific mutagenesis ↗

  Biochemistry · 1993 · PMID 8399217
  not yet assessed